Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
A Corrigendum on
Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
by Hwang I, Jin Z, Park J-W, Kwon O-S, Lim B, Hong M, Kim M, Yu H-T, Kim T-H, Uhm J-S, Joung B, Lee M-H and Pak H-N (2021). Front. Physiol. 12:650449. doi: 10.3389/fphys.2021.650449
In the published article, there was an error in the Author List. Author “Ze Jin” was erroneously excluded. The corrected author list appears below:
“Inseok Hwang; Ze Jin; Je-Wook Park; Oh-Seok Kwon; Byounghyun Lim; Myunghee Hong; Min Kim; Hee-Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak.”
In the published article, there was an error in Supplementary Table S1. The ion currents for baselines and AADs were described incorrectly. The corrected Supplementary Table S1 appears in the Supplementary material.
In the published article, there was an error. The Author Contributions were described incorrectly:
“H-NP was participated in the study design, study protocol design, data review, and writing manuscript. IH was involved in the data collection, analysis, and writing manuscript. J-WP was involved in the data interpretation and statistical analysis. O-SK was participated in the study tool design. BL was involved in the data collection, and study protocol design. MH, MK, and H-TY were participated in the data interpretation. T-HK, J-SU, BJ, and M-HL were involved in the data interpretation and data review. All authors contributed to the article and approved the submitted version.”
The corrected Author Contributions statement appears below:
“H-NP participated in the study design, study protocol design, data review, and writing manuscript. IH and ZJ was involved in the data collection, analysis, and writing manuscript. J-WP was involved in the data interpretation and statistical analysis. O-SK participated in the study tool design. BL was involved in the data collection, and study protocol design. MH, MK, and H-TY participated in the data interpretation. T-HK, J-SU, BJ, and M-HL were involved in the data interpretation and data review. All authors contributed to the article and approved the submitted version.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphys.2021.650449/full#supplementary-material
Keywords: atrial fibrillation, modeling, antiarrhythmic drugs, PITX2, gene
Citation: Hwang I, Jin Z, Park J-W, Kwon O-S, Lim B, Hong M, Kim M, Yu H-T, Kim T-H, Uhm J-S, Joung B, Lee M-H and Pak H-N (2022) Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype. Front. Physiol. 13:991997. doi: 10.3389/fphys.2022.991997
Received: 12 July 2022; Accepted: 21 November 2022;
Published: 02 December 2022.
Edited and reviewed by:
Chae Hun Leem, University of Ulsan, South KoreaCopyright © 2022 Hwang, Jin, Park, Kwon, Lim, Hong, Kim, Yu, Kim, Uhm, Joung, Lee and Pak. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hui-Nam Pak, hnpak@yuhs.ac